Heather Cazzolli

1 CBL , CBLB , TET 2 , ASXL 1 and IDH 1 / 2 Mutations and Additional Chromosomal Aberrations Constitute Molecular Events in Chronic Myelogenous Leukemia

A. Jankowska, M. McDevitt, C. O'keefe, 2011 .

Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia.

A. Jankowska, C. O'keefe, J. Maciejewski, 2010, Blood.

Molecular Lesions Associated with Loss of Heterozygosity Identified in CMML.

R. Ganetzky, A. Jankowska, M. McDevitt, 2009 .

CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.

Michael A McDevitt, Eric Hsi, John Nicoll, 2011, Blood.

Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia

M. Wlodarski, J. Maciejewski, N. Bejanyan, 2009, Haematologica.

CBL , CBLB , TET 2 , ASXL 1 , and IDH 1 / 2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia

Michael A. McDevitt, Eric Hsi, John Nicoll, 2011 .

Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.

M. McDevitt, C. O'keefe, J. Maciejewski, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CBL, CBLB, TET2, ASXL1, and IDH1/2 Mutations as Well as Additional Chromosomal Aberrations Constitute Molecular Events Contributing to Malignant Progression In Advanced Philadelphia Chromosome-Positive Disorders.

A. Jankowska, M. McDevitt, J. Maciejewski, 2010 .

Cbl and TET2 Mutations Are Present in Refractory Ph+ Disorders Including Accelerated and Blast Crisis CML and ALL.

A. Jankowska, M. McDevitt, J. Maciejewski, 2009 .

Impact of TET2 mutations on responsiveness to demethylating agents in MDS

R. Ganetzky, A. Jankowska, J. Maciejewski, 2010 .